Top Biotechnology companies in Canada by Price to Book Ratio (P/B)

This ranking features the top 4 Biotechnology companies in Canada ranked by Price to Book Ratio (P/B), averaging a Price to Book Ratio (P/B) of 1.05, for January 15, 2025.

Canada

Biotechnology
Price to Book Ratio (P/B)
#
Name
Price to Book Ratio (P/B)
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
BRM.V

BioRem Inc.

1

BRM.V

6.49

 Jan. 14, 2025 USD 2.08 1.92%

Canada
2
XRTX.V

XORTX Therapeutics Inc.

2

XRTX.V

0.87

 Jan. 14, 2025 USD 1.25 -0.34%

Canada
3
EPIX

ESSA Pharma Inc.

3

EPIX

0.60

 Jan. 14, 2025 USD 1.77 2.31%

Canada
4
TH.TO

Theratechnologies Inc.

4

TH.TO

-3.78

 Jan. 14, 2025 USD 1.71 4.46%

Canada
Frequently Asked Questions
  • Which Biotechnology company in Canada has the highest Price to Book Ratio (P/B) ?

    The Biotechnology company in Canada with the highest Price to Book Ratio (P/B) is BioRem Inc. (TSXV: BRM.V) at 6.49.

  • Which Biotechnology company in Canada has the lowest Price to Book Ratio (P/B) ?

    The Biotechnology company in Canada with the lowest Price to Book Ratio (P/B) is Theratechnologies Inc. (Toronto Stock Exchange: TH.TO) at -3.78.